Please try another search
Pieris Pharmaceuticals, Inc., a biotechnology company, discovers and develops biotechnological applications. The company focuses on the development of its 4-1BB bispecifics immuno-oncology (IO) programs. Its clinical pipeline consists of IO bispecifics, including S095012 (PRS-344), a bispecific Mabcalin compound targeting PD-L1 and 4-1BB in partnership with Les Laboratoires Servier and Institut de Recherches Internationales Servier; SGN-BB228 (PRS-346), a CD228 x 4-1BB bispecific antibody-Anticalin compound targeting CD228 and 4-1BB in partnership with Pfizer Inc.; and BOS-342 (PRS-342), a GPC3 x 4-1BB bispecific Mabcalin compound targeting GPC3 and 4-1BB in partnership with Boston Pharmaceuticals, which are in phase 1 studies. The company was founded in 2001 and is headquartered in Boston, Massachusetts.
Name | Age | Since | Title |
---|---|---|---|
Stephen S. Yoder | 47 | 2010 | CEO, President & Director |
Bruce Levy | - | - | Member of Clinical & Scientific Advisory Board |
Michael S. Richman | 62 | 2014 | Independent Director |
Peter Barnes | - | - | Member of Clinical & Scientific Advisory Board |
Padmanee Sharma | - | - | Member of Clinical & Scientific Advisory Board |
Vijay Kumar Kuchroo | 68 | - | Member of Clinical & Scientific Advisory Board |
Christopher P. Kiritsy | 58 | 2016 | Independent Director |
Peter A. Kiener | 71 | 2018 | Independent Director |
Ian Adcock | - | - | Member of Clinical & Scientific Advisory Board |
Gary Anderson | - | - | Member of Clinical & Scientific Advisory Board |
Dario A. Vignali | - | - | Member of Clinical & Scientific Advisory Board |
Matthew L. Sherman | 67 | 2018 | Independent Director |
Oliver Eickelberg | - | - | Member of Clinical & Scientific Advisory Board |
James Arthur Geraghty | 68 | 2017 | Independent Chairman |
Maya R. Said | 46 | 2019 | Independent Director |
David Schwartz | - | - | Member of Clinical & Scientific Advisory Board |
E. John Werry | - | - | Member of Clinical & Scientific Advisory Board |
Michael A. Curran | - | - | Member of Clinical & Scientific Advisory Board |
Ann Barbier | 59 | 2018 | Independent Director |
Fan Chung | - | - | Member of Clinical & Scientific Advisory Board |
Sally Wenzel | - | - | Member of Clinical & Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review